"The problems with this are obvious," said Capizzi. These kinds of tests "treat human beings as things to be produced, sold or bought."
Although those behind test say they do not specifically seek to identify embryos that contain genes linked to higher intelligence, Genomic Prediction co-founder Stephen Hsu said that he believes there will be a demand for this service in the future.
"I think people are going to demand that. If we don't do it, some other company will," said Hsu in New Scientist.
Currently, something called a "polygenic risk score" can be calculated for adults. This score is calculated after an examination of a person's genes to identify increased risks for heart disease, dementia, or breast cancer. Until now, this has not been available for embryos.
Capizzi warned that a mentality of parents wanting a supposedly genetically perfect "designer" child will have dire effects on how people view others.
(Story continues below)
Subscribe to our daily newsletter
"The logic of this leads to parents demanding refunds or exchanges of their children when they don't turn out as promised," Capizzi said.
"Not only, in other words, will the commodification of human beings in this way lead to throwing away unwanted embryos, it will lead to the abandonment of unwanted young people."